comparemela.com

Latest Breaking News On - Crown advisors management - Page 1 : comparemela.com

William Blair Investment Management LLC Has $50 24 Million Stock Holdings in Grand Canyon Education, Inc (NASDAQ:LOPE)

William Blair Investment Management LLC Has $50 24 Million Stock Holdings in Grand Canyon Education, Inc (NASDAQ:LOPE)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Archrock, Inc (NYSE:AROC) Receives Consensus Recommendation of Buy from Analysts

Archrock, Inc. (NYSE:AROC – Get Free Report) has been given a consensus recommendation of “Buy” by the three research firms that are covering the stock, MarketBeat reports. Three research analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have updated their coverage on the stock in the […]

Short Interest in Flux Power Holdings, Inc (NASDAQ:FLUX) Increases By 5 5%

Flux Power Holdings, Inc. (NASDAQ:FLUX – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 299,700 shares, a growth of 5.5% from the September 30th total of 284,200 shares. Based on an average daily volume of 48,700 […]

Navigator (NYSE:NVGS) Rating Increased to Buy at StockNews com

Navigator (NYSE:NVGS – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Jefferies Financial Group restated a “buy” rating and issued a $18.00 price objective on shares of Navigator in a research report on Thursday, August 17th. Check […]

Crown Advisors Management Inc Takes Position in ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

Crown Advisors Management Inc. purchased a new stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) in the 1st quarter, Holdings Channel reports. The fund purchased 30,000 shares of the biopharmaceutical company’s stock, valued at approximately $564,000. Several other hedge funds and other institutional investors have also recently made changes to their positions […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.